HER2/neu-directed therapy for biliary tract cancer

BACKGROUND: Biliary cancers are highly aggressive tumors that are often diagnosed an advanced disease stage and have a poor outcome with systemic therapy. Recent efforts towards molecular characterization have identified a subset of biliary patients that have HER2/neu amplification or mutation. HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C., Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A., Kaseb, Ahmed O., Thomas, Melanie B., Siegel, Abby B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469402/
https://www.ncbi.nlm.nih.gov/pubmed/26022204
http://dx.doi.org/10.1186/s13045-015-0155-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469402/
https://www.ncbi.nlm.nih.gov/pubmed/26022204
http://dx.doi.org/10.1186/s13045-015-0155-z

Ejemplares similares